Warberg Asset Management’s Artelo Biosciences, Inc. Warrant ARTLW Stock Holding History

Warberg Asset Management’s Portfolio ARTLW Stock Details ARTLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-16,403	Closed	-$4K	–	192
2020 Q4	$4K	Buy	+16,403	New	+$1.86K	﹤0.01%	155

Other funds holding ARTLW

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Warberg Asset Management's ARTLW Position: Q1 2021 in Review

Warberg Asset Management sold out of Artelo Biosciences, Inc. Warrant (ARTLW) in Q1 2021, closing a stake of 16,403 shares — an estimated $4K sold.

Warberg Asset Management first reported a position in ARTLW in Q4 2020 and held it in 1 quarter. The position peaked at $4K in Q4 2020. 4 funds tracked by Wall St. Rank hold ARTLW as of Q1 2021.

Warberg Asset Management reported no remaining Artelo Biosciences, Inc. Warrant position as of Q1 2021 after selling out during the quarter.
Warberg Asset Management sold 16,403 Artelo Biosciences, Inc. Warrant shares in Q1 2021, an estimated $4K.
Warberg Asset Management first reported a position in Artelo Biosciences, Inc. Warrant in Q4 2020 and held it in 1 quarter.
Warberg Asset Management's Artelo Biosciences, Inc. Warrant position peaked at $4K in Q4 2020.
4 funds tracked by Wall St. Rank held Artelo Biosciences, Inc. Warrant as of Q1 2021.

Based on Warberg Asset Management's 13F filing for Q1 2021, filed 17 May 2021.